Tetravalent recombinant 16/18/52/58 human papillomavirus virus particle vaccine (ShuangLu Pharmaceutical)

四价重组16/18/52/58型人乳头瘤病毒类病毒颗粒疫苗（双鹭药业）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTetravalent recombinant 16/18/52/58 human papillomavirus virus particle vaccine (ShuangLu Pharmaceutical)

Drug Alias NameN/A

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Vaccine type > Multivalent vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaIND

Originator CompaniesBeijing Sl Pharmaceutical Co Ltd

China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Sl Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsPapillomavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A